Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ-A-018 in Adult Chronic Spontaneous Urticaria (Phase II Dose-Finding)
ChiCTR2600126658Phase 2Recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HZ-A-018 in chronic idiopathic urticaria (CIU) (4 arms), sponsored by Hangzhou First People's Hospital. Primary endpoints: Safety evaluation and Weekly Urticaria Activity Score (UAS7). Started Jun 2026; status: recruiting.
02
Drugs
HZ-A-018
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on ChiCTR2600126658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126658.